India to Croatia: Amlodipine Export Trade Route
India has recorded 42 verified shipments of Amlodipine exported to Croatia, representing a combined trade value of $15.0M USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $356.3K USD. The leading Indian exporter is IPCA LABORATORIES LIMITED, which accounts for 98% of total export value with 23 shipments worth $14.6M USD. On the buying side, NA is the largest importer in Croatia with $14.3M USD in purchases. The top 3 suppliers — IPCA LABORATORIES LIMITED, MACLEODS PHARMACEUTICALS LTD, IPCA LABORATORIES LIMITED — together control 99% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Croatia Amlodipine corridor is one of India's established pharmaceutical export routes, with 42 shipments documented worth a combined $15.0M USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 98% of all export value, reflecting the consolidated nature of India's amlodipine manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $356.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with amlodipine's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 32.1%, placing it at rank #20 among India's top amlodipine export destinations globally.
On the import side, key buyers of Indian amlodipine in Croatia include NA, BELUPO PHARMACEUTICAL AND COSMETICS, Pharma S and 5 others. NA is the single largest importer with 8 shipments valued at $14.3M USD.
